Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 25/2/2021
SIETES contiene 93212 citas

 
 
 1 a 20 de 37 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S, COMPASS Investigators. Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial. Gastroenterology 2019;157:agosto. [Ref.ID 103177]
2. Cita con resumen
Connolly SJ, Milling Jr TJ, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albadalejo P, López-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M, for the ANNEXA-4 Investigators. Andexanet alfa for acute major bleeding associated with factor Xa inhibotors. N Engl J Med 2016;375:1131-41. [Ref.ID 100767]
3.Tiene citas relacionadas Cita con resumen
Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Stat C, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt J-U, Simoons ML, Van de Werf F, for the RE-ALIGN Investigators. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 2013;369:1206-14. [Ref.ID 96301]
4.Tiene citas relacionadas Cita con resumen
Brighton TA, Eikelboom JW, Simes J. Aspirin for preventing venous thromboembolism. Author/editor response. N Engl J Med 2013;368:773. [Ref.ID 94967]
5.Tiene citas relacionadas Cita con resumen
Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J, for the ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 2012;367:1979-87. [Ref.ID 94109]
6.Tiene citas relacionadas
Eikelboom JW, Connolly SJ. Warfarin and health failure. N Engl J Med 2012;366:1936-8. [Ref.ID 92986]
7.Enlace a cita original
Paikin JS, Eikelboom JW. Aspirin. Circulation 2012;125:e439-42. [Ref.ID 92260]
8.Enlace a cita original
Eikelboom JW, Weitz JI. New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty. BMJ 2011;342:224-7. [Ref.ID 90144]
9.Tiene citas relacionadas
Mehta SR, Eikelboom JW, Yusuf S. Double-dose clopidogrel in patients undergoing PCI for ACS. Authors' reply. Lancet 2011;377:298. [Ref.ID 90123]
10.Tiene citas relacionadas
Mehta SR, Eikelboom JW, Yusuf S. Dosing of clopidogrel and aspirin in acute coronary syndromes. The authors reply. N Engl J Med 2010;363:2467-8. [Ref.ID 89805]
11. Cita con resumen
Paré G, Mehta SR, Yusuf S, Anand SS, Connolly SJ, Hirsh J, Simonsen K, Bhatt DL, Fox KAA, Eikelboom JW. Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med 2010;363:1704-14. [Ref.ID 89554]
12.Tiene citas relacionadas Cita con resumen
Mehta S, Tanguay JF, Eikelboom JW, Jolly SS, Joyner CD, Granger CB, Faxon DP, Rupprecht H-J, Budaj A, Avezum A, Widimsky P, Steg PG, Bassand J-P, Montalescot G, Macaya C, Di Pasquale G, Niemela K, Ajani AE, White HD, Chrolavicius S, Gao P, Fox KAA, Yusuf S, on behalf of the CURRENT-OASIS 7 trial investigators. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in invididuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial. Lancet 2010;376:1233-43. [Ref.ID 89553]
13.Tiene citas relacionadas
Eikelboom JW, Weitz JI. Otamixaban in acute coronary syndromes. Lancet 2009;374:762-4. [Ref.ID 86735]
14.Tiene citas relacionadas Cita con resumen
Raju NC, Dimmitt S, Eikelboom JW. Rivaroxaban versus enoxaparin after total knee arthroplasty. Lancet 2009;374:681. [Ref.ID 86643]
15.Tiene citas relacionadas
Eikelboom JW, O'Donnell M. Using aspirin to prevent cognitive decline. BMJ 2008;337:525-6. [Ref.ID 84014]
16.Tiene citas relacionadas Cita con resumen
Eikelboom JW, Weitz JI. Selective factor Xa inhibition for thromboprophylaxis. Lancet 2008;372:6-8. [Ref.ID 83487]
17.Tiene citas relacionadas Cita con resumen
Eikelboom JW, Ginsberg JS, Hirsh J. Anticoagulation for venous thromboembolism. BMJ 2007;334:645. [Ref.ID 79696]
18.Tiene citas relacionadas
Sun JCJ, Eikelboom JW. Treatment of restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2007;356:1071. [Ref.ID 79511]
20.Tiene citas relacionadas Cita con resumen
O'Donnell M, Eikelboom JW. ESPRIT trial. Lancet 2006;368:447. [Ref.ID 77647]
Seleccionar todas
 
 1 a 20 de 37 siguiente >>